January 22, 2020

A contemporary look at allergic conjunctivitis

  • Review
  • Open Access

Allergy, Asthma & Clinical Immunology

Abstract
Ocular signs of (a) chronic perennial allergic conjunctivitis
(
bd) acute seasonal allergic conjunctivitis. 
Allergic eye disease is common, yet often overlooked in North America. In the U.S., up to 40% of the population is deemed to be affected and this number is growing. Symptoms and signs of ocular allergy can lead to decreased productivity and negatively impact quality of life (QoL). Various treatment options exist to achieve symptom control. For allergic conjunctivitis, ophthalmic agents include antihistamines, mast cell stabilizers, dual-activity agents, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and some off-label treatments. Immunotherapy is recommended as a therapeutic option.

Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice

Abstract
Background
Studies have shown the discrepancy between self-reported antibiotic allergies and true allergies. Inaccurate reporting of antibiotic hypersensitivities can limit treatment options and result in use of more expensive antibiotics and contribute to resistance.

January 20, 2020

Indoor mold odor in the workplace increases the risk of Asthma-COPD Overlap Syndrome: a population-based incident case–control study

  • Research
  • Open Access
Abstract
Background
Previous studies have suggested an increased risk of asthma related to indoor dampness problems, but their role in the etiology of Asthma-COPD Overlap Syndrome has not been studied. We utilized a population-based incident case–control study to assess potential effect of indoor dampness and molds at home and at work on development of ACOS.

January 18, 2020

Healthy people in healthy premises: the Finnish Indoor Air and Health Programme 2018–2028

  • Research
  • Open Access

Abstract
Main focus areas of Finnish Healthy Premises 2028 Programme.
The Finnish Indoor Air and Health Programme implements
and supports these measures (Enhancement of health and well-being)
 and closely collaborates with programme’s other actors
Clean and fresh indoor air supports health and well-being. However, indoor air can contain pollutants that can cause a variety of symptoms and reduce well-being. Individual exposure agents can also increase the risk of certain diseases. Finns have taken major steps to improve the quality of indoor air for several decades. The primary focus of these activities has been the prevention and reduction of exposure to poor indoor air quality through guidance and regulation directing remediation of damaged buildings. Nevertheless, reported symptoms related to poor indoor air quality are common in Finland.

January 16, 2020

Association between atopic dermatitis and colorectal cancer risk

RESEARCH ARTICLE: OBSERVATIONAL STUDY

A nationwide cohort study

Chou, Wan-Yun MSa; Lai, Pin-Yu MSb; Hu, Je-Ming MDc,d,e; Hsu, Chih-Hsiung MSc,f; Chen, Yong-Chen PhDg,h; Tian, Yu-Feng MDi,j; You, San-Lin PhDg,h; Hsiao, Cheng-Wen MDd; Chou, Yu-Ching PhDa,b,∗; Sun, Chien-An ScDh,k,∗
Section Editor(s): Kok., Victor C.
 Author Information

Abstract

The role of atopic dermatitis (AD) in the development of colorectal cancer (CRC) has been a matter of scientific debate with mixed results. We conducted a nationwide cohort study to assess the association between AD and risk of CRC. Drawing on Taiwan's National Health Insurance Research Database, 46,703 patients with AD (the AD cohort) and 186,812 sex, age, and index year-matched patients without AD (the non-AD cohort) were identified in the period between 2000 and 2008.

January 15, 2020

Clinical Management of Seafood Allergy

January 7, 2020

Use of antibiotics and asthma medication for acute lower respiratory tract infections in people with and without asthma: retrospective cohort study

  • Research
  • Open Access
Abstract
Background
Antibiotics are overused in patients with acute lower respiratory tract infections (ALRTIs), but less is known about their use in patients with asthma, or the use of asthma medication for ALRTI in patients without asthma. Our aim was to describe the frequency, variation and drivers in antibiotic and asthma medication prescribing for ALRTI in adults with and without asthma in primary care.

January 4, 2020

Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care

Heimo Breiteneder  Zuzana Diamant  Thomas Eiwegger  Wytske J. Fokkens  Claudia Traidl‐Hoffmann  Kari Nadeau  Robyn E. O’Hehir  Liam O’Mahony  Oliver Pfaar  Maria J. Torres  De Yun Wang  Luo Zhang  Cezmi A. Akdis 

REVIEW Open Access

Abstract


The specialties of allergy and clinical immunology have entered the era of precision medicine with the stratification of diseases into distinct disease subsets, specific diagnoses, and targeted treatment options, including biologicals and small molecules. 
This article reviews recent developments in research and patient care and future trends in the discipline. The section on basic mechanisms of allergic diseases summarizes the current status and defines research needs in structural biology, type 2 inflammation, immune tolerance, neuroimmune mechanisms, role of the microbiome and diet, environmental factors, and respiratory viral infections. In the section on diagnostic challenges, clinical trials, precision medicine and immune monitoring of allergic diseases, asthma, allergic and nonallergic rhinitis, and new approaches to the diagnosis and treatment of drug hypersensitivity reactions are discussed in further detail.